| scholarly article | Q13442814 |
| P50 | author | Marnix Jansen | Q77321797 |
| Christophe Rosty | Q51118591 | ||
| Michael Goggins | Q63021511 | ||
| P2093 | author name string | N Sato | |
| C A Iacobuzio-Donahue | |||
| C J Yeo | |||
| R H Hruban | |||
| J L Cameron | |||
| T Ueki | |||
| N Fukushima | |||
| P2860 | cites work | The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death | Q24291382 |
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers | Q24671334 | ||
| A serine/threonine kinase gene defective in Peutz-Jeghers syndrome | Q28119198 | ||
| Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase | Q28258611 | ||
| Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer | Q28267211 | ||
| Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas | Q73555144 | ||
| Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases | Q73727599 | ||
| Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity | Q74428893 | ||
| Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas | Q74797697 | ||
| Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas | Q78023166 | ||
| Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis | Q28300857 | ||
| A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. | Q33647782 | ||
| Progress in cancer genetics: lessons from pancreatic cancer | Q33705143 | ||
| Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer | Q34269104 | ||
| Increased risk for cancer in patients with the Peutz-Jeghers syndrome | Q34472625 | ||
| Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest | Q34504424 | ||
| Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome | Q34506538 | ||
| Increased risk of cancer in the Peutz-Jeghers syndrome | Q34690977 | ||
| Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients | Q34722833 | ||
| Tumor-suppressive pathways in pancreatic carcinoma. | Q34739925 | ||
| Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors | Q34747457 | ||
| STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. | Q34754689 | ||
| An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers | Q35394836 | ||
| Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. | Q35764095 | ||
| Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections | Q35764415 | ||
| BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications | Q35810230 | ||
| Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas | Q35829440 | ||
| Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. | Q36620205 | ||
| Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis | Q36622459 | ||
| Conversion of diploidy to haploidy | Q40897610 | ||
| Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases | Q42075775 | ||
| Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation | Q42791516 | ||
| Intraductal neoplasms of the pancreas | Q45111547 | ||
| Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic | Q48785820 | ||
| Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. | Q53398379 | ||
| Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. | Q53439727 | ||
| Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. | Q54190005 | ||
| Generalized Intestinal Polyposis and Melanin Spots of the Oral Mucosa, Lips and Digits | Q57073474 | ||
| Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome | Q57240072 | ||
| Cancer in Peutz-Jeghers syndrome | Q70487226 | ||
| Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia". Histochemical and immunohistochemical analysis of 29 cases | Q72181018 | ||
| An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas | Q72221463 | ||
| Allelotype of pancreatic adenocarcinoma | Q72386220 | ||
| The prognosis of intraductal papillary mucinous tumors of the pancreas | Q73046073 | ||
| Atomic structure of the quasicrystal Al72Ni20Co8 | Q73412325 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 2017-2022 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas | |
| P478 | volume | 159 |
| Q37562982 | A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Biliary Duct in a Patient with Prostate Adenocarcinoma |
| Q35889483 | A histomorphologic comparison of familial and sporadic pancreatic cancers |
| Q42409627 | A new approach to managing intraductal papillary mucinous pancreatic neoplasms |
| Q91387240 | A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination |
| Q38998413 | AMPK and Cancer |
| Q34635042 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. |
| Q54373054 | Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma. |
| Q35783104 | BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas |
| Q37411831 | Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis |
| Q96817986 | Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center |
| Q31121505 | Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays |
| Q33763660 | Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors |
| Q34100230 | Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas |
| Q47427450 | Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes |
| Q75404779 | Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas |
| Q42053166 | CpG island methylation profile of pancreatic intraepithelial neoplasia |
| Q38261961 | Current and future intratumoral targeted treatment for pancreatic cancer. |
| Q80281952 | Cystic lesions of the pancreas |
| Q35609914 | Cystic precursors to invasive pancreatic cancer |
| Q34548697 | De novo germline mutation in the serine-threonine kinase STK11/LKB1 gene associated with Peutz-Jeghers syndrome |
| Q36293714 | Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma. |
| Q33635144 | Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm |
| Q35123631 | Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma |
| Q27010209 | Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer |
| Q37994998 | Energy metabolism and proliferation in pancreatic carcinogenesis |
| Q36542823 | Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas |
| Q37918870 | Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals |
| Q37346042 | Familial pancreatic cancer: from genes to improved patient care |
| Q34658718 | Familial pancreatic cancer: genetic advances |
| Q35934053 | Familial pancreatic carcinoma in Jews |
| Q57767553 | From tissue turnover to the cell of origin for pancreatic cancer |
| Q35094629 | Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas |
| Q57091632 | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
| Q24801465 | Genetic alterations in pancreatic carcinoma |
| Q37271839 | Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates |
| Q21129230 | Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma |
| Q30504615 | Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas |
| Q98471377 | Genomic characterization of malignant progression in neoplastic pancreatic cysts |
| Q35170720 | Genomic landscapes of pancreatic neoplasia |
| Q37727837 | Germinal center kinases in immune regulation. |
| Q33721668 | Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells |
| Q37480736 | Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients |
| Q46038945 | Inherited predisposition to cancer: a historical overview. |
| Q36648118 | International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer |
| Q37073180 | Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome |
| Q34657866 | Intraductal papillary mucinous neoplasm of the pancreas: an update |
| Q37990820 | Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease |
| Q36416291 | Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival |
| Q78424273 | Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics |
| Q41131015 | Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology |
| Q54587965 | K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. |
| Q24299520 | Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas |
| Q37066190 | LIM only 4 is overexpressed in late stage pancreas cancer |
| Q37543834 | LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism |
| Q37165210 | LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest |
| Q37868986 | LKB1 signaling in advancing cell differentiation |
| Q34534892 | LKB1, a protein kinase regulating cell proliferation and polarity |
| Q34553801 | LKB1, the multitasking tumour suppressor kinase |
| Q37333592 | LKB1; linking cell structure and tumor suppression |
| Q34899298 | Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers |
| Q39471948 | Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis |
| Q37558614 | Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas |
| Q73670302 | Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms |
| Q39469747 | Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas |
| Q37249650 | Management of mucin-producing cystic neoplasms of the pancreas |
| Q91272507 | Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection |
| Q90704103 | Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report |
| Q37365603 | Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth |
| Q41614903 | Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma |
| Q24649254 | MicroRNA miR-155 is a biomarker of early pancreatic neoplasia |
| Q80089395 | Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome |
| Q36829529 | Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas. |
| Q37960816 | Molecular pathogenesis of pancreatic cancer and clinical perspectives |
| Q34008627 | Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas |
| Q33918801 | Molecular signatures of pancreatic cancer |
| Q37183611 | Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. |
| Q37558631 | Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas. |
| Q36234845 | Mutations in the human LKB1/STK11 gene |
| Q34568396 | Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity |
| Q26796500 | Natural History and Management of Intraductal Papillary Mucinous Neoplasms: Current Evidence |
| Q35606891 | PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas |
| Q37558625 | PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. |
| Q48594379 | Pancreatic Cancer Screening |
| Q41982039 | Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms |
| Q26799446 | Pancreatic adenocarcinoma pathology: changing "landscape" |
| Q38113752 | Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy |
| Q36681492 | Pancreatic cystic neoplasms: a review of preoperative diagnosis and management |
| Q35152407 | Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome |
| Q33581119 | Pathology and molecular genetics of pancreatic neoplasms |
| Q36135660 | Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. |
| Q33855814 | Precursor lesions of pancreatic cancer |
| Q24626346 | Recent progress in pancreatic cancer |
| Q37117829 | Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis |
| Q38196268 | Rewiring cell polarity signaling in cancer |
| Q37617965 | Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer |
| Q33754040 | Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas |
| Q34601452 | The epidemiology and pathogenesis of neoplasia in the small intestine |
| Q36451732 | The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers |
| Q35801829 | The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians |
| Q39097606 | The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma |
| Q37934215 | The tumor suppressor kinase LKB1: lessons from mouse models |
| Q36685267 | Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis |
| Q57953769 | Update on Familial Pancreatic Cancer |
| Q81127474 | [Intraductal neoplasms of the pancreas: cystic and common] |
| Q53220247 | [Precursor lesions of pancreatobiliary cancer]. |
Search more.